Large-scale adenovirus and poxvirus-vectored vaccine manufacturing to enable clinical trials.

Kallel H, Kamen AA

Open source

DOI
10.1002/biot.201400390
Published
2015 May
Container
Biotechnology journal
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/biot.201400390,
  title = {Large-scale adenovirus and poxvirus-vectored vaccine manufacturing to enable clinical trials.},
  author = {Kallel H and Kamen AA},
  year = {2015},
  journal = {Biotechnology journal},
  doi = {10.1002/biot.201400390},
  url = {https://doi.org/10.1002/biot.201400390}
}

RIS

TY  - JOUR
TI  - Large-scale adenovirus and poxvirus-vectored vaccine manufacturing to enable clinical trials.
AU  - Kallel H
AU  - Kamen AA
PY  - 2015
JO  - Biotechnology journal
DO  - 10.1002/biot.201400390
UR  - https://doi.org/10.1002/biot.201400390
ER  - 

APA

H, K., & AA, K. (2015). Large-scale adenovirus and poxvirus-vectored vaccine manufacturing to enable clinical trials.. Biotechnology journal. https://doi.org/10.1002/biot.201400390

Source records